Protagen Partners with the National Cancer Institute for Biomarker Research

News   Feb 03, 2017 | Original Story From Protagen

 
Protagen Partners with the National Cancer Institute for Biomarker Research
 
 
 

RELATED ARTICLES

Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein Target

News

A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.

READ MORE

Study Sets New Standards for Liquid Biopsy

News

A new study helps set standards for RNA sequencing, improving standard practice and laying the foundation to move the field forward.

READ MORE

Hidden Signals in RNAs Regulate Protein Synthesis

News

Scientists have long known that RNA encodes instructions to make proteins. In a new study published in Nature, scientists describe how the protein-making machinery identifies alternative initiation sites from which to start protein synthesis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy